Zobrazeno 91 - 100
of 100
pro vyhledávání: '"Long, Henry W."'
Autor:
Dreijerink, Koen M. A., Groner, Anna C., Voc, Erica S.M., Font-Tello, Alba, Gu, Lei, Chi, David, Reyes, Jaime, Cook, Jennifer, Lim, Elgene, Lin, Charles Y., de laat, Wouter, Rao, Prakash K., Long, Henry W., Brown, Myles
While the multiple endocrine neoplasia type 1 (MEN1) gene functions as a tumor suppressor in a variety of cancer types, we explored its oncogenic role in breast tumorigenesis. The MEN1 gene product menin is involved in H3K4 trimethylation and co-acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd1ad1eea64de29fea4d9e23e42a7b75
Autor:
Seehawer M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Li Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Nishida J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Foidart P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Reiter AH; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA., Rojas-Jimenez E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Goyette MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Yan P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Raval S; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA., Munoz Gomez M; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Cejas P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Long HW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Papanastasiou M; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.
Publikováno v:
Nature cell biology [Nat Cell Biol] 2024 Jul; Vol. 26 (7), pp. 1165-1175. Date of Electronic Publication: 2024 Jun 26.
Autor:
Poluben L, Nouri M, Liang J, Varkaris A, Ersoy-Fazlioglu B, Voznesensky O, Lee II, Qiu X, Cato L, Seo JH, Freedman ML, Sowalsky AG, Lack NA, Corey E, Nelson PS, Brown M, Long HW, Russo JW, Balk SP
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Jun 24. Date of Electronic Publication: 2024 Jun 24.
Autor:
Luo Q, Raulston EG, Prado MA, Wu X, Gritsman K, Yan K, Booth CAG, Xu R, van Galen P, Doench JG, Shimony S, Long HW, Neuberg DS, Paulo JA, Lane AA
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Dec 15. Date of Electronic Publication: 2023 Dec 15.
Autor:
Chin HG; New England Biolabs Inc., Ipswich, MA, USA., Vishnu US; New England Biolabs Inc., Ipswich, MA, USA., Sun Z; New England Biolabs Inc., Ipswich, MA, USA., Ponnaluri VKC; New England Biolabs Inc., Ipswich, MA, USA., Zhang G; New England Biolabs Inc., Ipswich, MA, USA., Xu SY; New England Biolabs Inc., Ipswich, MA, USA., Benoukraf T; Faculty of Medicine, Craig L. Dobbin Genetics Research Centre, Memorial University of Newfoundland, St. John's, NL, Canada., Cejas P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Spracklin G; Program in Systems Biology, University of Massachusetts Medical School, Worcester, MA, USA., Estève PO; New England Biolabs Inc., Ipswich, MA, USA., Long HW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Pradhan S; New England Biolabs Inc., Ipswich, MA, USA. pradhan@neb.com.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2023; Vol. 2611, pp. 39-52.
Autor:
Schaefer EJ; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Wang HC; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Karp HQ; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Meyer CA; Department of Data Science, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Cejas P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Gearhart MD; Developmental Biology Center, Masonic Cancer Center, and Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, Minnesota., Adelman ER; Sylvester Comprehensive Cancer Center, Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, Florida.; Department of Biochemistry and Molecular Biology, University of Miami, Miller School of Medicine, Miami, Florida., Fares I; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Apffel A; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Lim K; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Xie Y; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Gibson CJ; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Schenone M; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Murdock HM; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Wang ES; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Gondek LP; Division of Molecular Pathology, Department of Pathology, Johns Hopkins University, Baltimore, Maryland., Carroll MP; Department of Medicine, Perelman Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Vedula RS; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Winer ES; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Garcia JS; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Stone RM; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Luskin MR; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Carr SA; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Long HW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Bardwell VJ; Developmental Biology Center, Masonic Cancer Center, and Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, Minnesota., Figueroa ME; Sylvester Comprehensive Cancer Center, Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, Florida., Lindsley RC; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2022 Mar 01; Vol. 3 (2), pp. 116-135.
Autor:
Cejas P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. paloma_cejas@dfci.harvard.edu.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. paloma_cejas@dfci.harvard.edu.; Translational Oncology Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ) and CIBERONC, La Paz University Hospital, Madrid, Spain. paloma_cejas@dfci.harvard.edu., Long HW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Henry_Long@dfci.harvard.edu.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. Henry_Long@dfci.harvard.edu.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2458, pp. 259-267.
Autor:
Zarei M; Cancer Genetics Laboratory, Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, USA., Giannikou K; Cancer Genetics Laboratory, Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Du H; Cancer Genetics Laboratory, Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Liu HJ; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Duarte M; Center for Functional Cancer Epigenetics, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Johnson S; Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, USA., Nassar AH; Cancer Genetics Laboratory, Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Widlund HR; Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Henske EP; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Long HW; Center for Functional Cancer Epigenetics, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Kwiatkowski DJ; Cancer Genetics Laboratory, Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. dk@rics.bwh.harvard.edu.
Publikováno v:
Oncogene [Oncogene] 2021 Jan; Vol. 40 (1), pp. 112-126. Date of Electronic Publication: 2020 Oct 20.
Autor:
Singhal H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Greene ME; Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois, USA., Zarnke AL; Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois, USA., Laine M; Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois, USA., Al Abosy R; Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois, USA., Chang YF; Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois, USA., Dembo AG; Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois, USA., Schoenfelt K; Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois, USA., Vadhi R; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Qiu X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Rao P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Santhamma B; Evestra Inc., San Antonio, Texas, USA., Nair HB; Evestra Inc., San Antonio, Texas, USA., Nickisch KJ; Evestra Inc., San Antonio, Texas, USA., Long HW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Becker L; Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois, USA., Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Greene GL; Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois, USA.
Publikováno v:
Oncotarget [Oncotarget] 2017 Sep 28; Vol. 9 (4), pp. 4282-4300. Date of Electronic Publication: 2017 Sep 28 (Print Publication: 2018).